132 related articles for article (PubMed ID: 27388155)
1. CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide.
Labib RM; A Abdelrahim ME; Elnadi E; Hesham RM; Yassin D
PLoS One; 2016; 11(7):e0158890. PubMed ID: 27388155
[TBL] [Abstract][Full Text] [Related]
2. Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer.
Haroun F; Al-Shaar L; Habib RH; El-Saghir N; Tfayli A; Bazarbachi A; Salem Z; Shamseddine A; Taher A; Cascorbi I; Zgheib NK
Cancer Chemother Pharmacol; 2015 Jan; 75(1):207-14. PubMed ID: 25428516
[TBL] [Abstract][Full Text] [Related]
3. Distribution of alleles, genotypes and haplotypes of the CYP2B6 (rs3745274; rs2279343) and CYP3A4 (rs2740574) genes in the Malian population: Implication for pharmacogenetics.
Kassogue Y; Diakite B; Kassogue O; Konate I; Tamboura K; Diarra Z; Maiga M; Dehbi H; Nadifi S; Traore CB; Kamate B; Dao S; Doumbia S; Dolo G
Medicine (Baltimore); 2021 Jul; 100(29):e26614. PubMed ID: 34398016
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles.
Restrepo JG; Martínez C; García-Agúndez A; Gaviria E; Laguna JJ; García-Martín E; Agúndez JA
Pharmacogenet Genomics; 2011 Dec; 21(12):773-8. PubMed ID: 21886015
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma.
Bachanova V; Shanley R; Malik F; Chauhan L; Lamba V; Weisdorf DJ; Burns LJ; Lamba JK
Biol Blood Marrow Transplant; 2015 May; 21(5):944-8. PubMed ID: 25677220
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients.
Shalaby N; Zaki HF; Badary OA; Kamal S; Nagy M; Makhlouf D; Elnashar A; Elnadi E; Abdelshafi SA; Abouelnaga S; Saber MM
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1391-1409. PubMed ID: 38680001
[TBL] [Abstract][Full Text] [Related]
7. Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.
Shu W; Guan S; Yang X; Liang L; Li J; Chen Z; Zhang Y; Chen L; Wang X; Huang M
Br J Clin Pharmacol; 2016 Feb; 81(2):327-40. PubMed ID: 26456622
[TBL] [Abstract][Full Text] [Related]
8. Distinctiveness of the Roma population within CYP2B6 worldwide variation.
Tomas Ž; Kuhanec A; Škarić-Jurić T; Petranović MZ; Narančić NS; Janićijević B; Salihović MP
Pharmacogenomics; 2017 Nov; 18(17):1575-1587. PubMed ID: 29095103
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.
Pinto N; Navarro SL; Rimorin C; Wurscher M; Hawkins DS; McCune JS
Pediatr Blood Cancer; 2021 Nov; 68(11):e29203. PubMed ID: 34245211
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.
Nakajima M; Komagata S; Fujiki Y; Kanada Y; Ebi H; Itoh K; Mukai H; Yokoi T; Minami H
Pharmacogenet Genomics; 2007 Jun; 17(6):431-45. PubMed ID: 17502835
[TBL] [Abstract][Full Text] [Related]
11. The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa.
Song Q; Zhou X; Yu J; Dong N; Wang X; Yang H; Ren J; Lyerly HK
Sci Rep; 2015 Nov; 5():16775. PubMed ID: 26602960
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.
Veal GJ; Cole M; Chinnaswamy G; Sludden J; Jamieson D; Errington J; Malik G; Hill CR; Chamberlain T; Boddy AV
Eur J Cancer; 2016 Mar; 55():56-64. PubMed ID: 26773420
[TBL] [Abstract][Full Text] [Related]
13. Allelic and genotype frequencies of major CYP2B6 polymorphisms in the Pakistani population.
Ahmed S; Khan S; Janjua K; Imran I; Khan AU
Mol Genet Genomic Med; 2021 Mar; 9(3):e1527. PubMed ID: 33599403
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection.
Peko SM; Gueye NSG; Vouvoungui C; Koukouikila-Koussounda F; Kobawila SC; Nderu D; Velavan TP; Ntoumi F
Int J Infect Dis; 2019 May; 82():111-116. PubMed ID: 30818046
[TBL] [Abstract][Full Text] [Related]
15. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA
J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200
[TBL] [Abstract][Full Text] [Related]
16. Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations.
Saʼad Toyin A; Julius Olugbenga S; Rahman Ayodele B; Olusola Joseph O; Taibat Moji BO
Am J Ther; 2016; 23(6):e1715-e1719. PubMed ID: 26938766
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of CYP2B6 polymorphisms in Argentinians: the role of genetic testing.
Scibona P; Vazquez C; Cajal AR; Argibay PF; Belloso WH
Genet Mol Res; 2015 Dec; 14(4):16594-9. PubMed ID: 26681005
[TBL] [Abstract][Full Text] [Related]
18. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of a CYP2B6 Gene Polymorphism in Patients with Acute Myeloid Leukemia.
Alazhary NM; Shafik RE; Shafik HE; Kamel MM
Asian Pac J Cancer Prev; 2015; 16(11):4583-7. PubMed ID: 26107207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
